Literature DB >> 18662133

Variants in the toll-like receptor signaling pathway and clinical outcomes of malaria.

Fabiana M S Leoratti1, Lilian Farias, Fabiana P Alves, Martha C Suarez-Mútis, José R Coura, Jorge Kalil, Erney P Camargo, Sandra L Moraes, Rajendranath Ramasawmy.   

Abstract

BACKGROUND: Malaria is one of the most significant infectious diseases in the world and is responsible for a large proportion of infant deaths. Toll-like receptors (TLRs), key components of innate immunity, are central to countering infection. Variants in the TLR-signaling pathway are associated with susceptibility to infectious diseases.
METHODS: We genotyped single nucleotide polymorphisms (SNPs) of the genes associated with the TLR-signaling pathway in patients with mild malaria and individuals with asymptomatic Plasmodium infections by means of polymerase chain reaction.
RESULTS: Genotype distributions for the TLR-1 I602S differed significantly between patients with mild malaria and persons with asymptomatic infection. The TLR-1 602S allele was associated with an odds ratio (OR) of 2.2 (P= .003; P(corrected)= .015) for malaria among patients with mild malaria due to any Plasmodium species and 2.1 (P= .015; P(corrected)= .75) among patients with mild malaria due to Plasmodium falciparum only. The TLR-6 S249P SNP showed an excess of homozygotes for the TLR-6 249P allele in asymptomatic persons, compared with patients with mild malaria due to any Plasmodium species (OR 2.1; 95% confidence interval [CI], 1.1- 4.2; P= .01; P(corrected)= .05), suggesting that the TLR-6 249S allele may be a risk factor for malaria (OR, 2.0; 95% CI, 1.1-3.7; P=0.01; P(corrected)= .05). The TLR-9 -1486C allele showed a strong association with high parasitemia (P< .001).
CONCLUSIONS: Our findings indicate that the TLR-1 and TLR-6 variants are significantly associated with mild malaria, whereas the TLR-9-1486C/T variants are associated with high parasitemia. These discoveries may bring additional understanding to the pathogenesis of malaria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18662133     DOI: 10.1086/590440

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

Review 1.  Toll-like receptors in innate immunity and infectious diseases.

Authors:  Min-Hao Wu; Ping Zhang; Xi Huang
Journal:  Front Med China       Date:  2010-12-02

2.  Genetic predisposition of variants in TLR2 and its co-receptors to severe malaria in Odisha, India.

Authors:  Subhendu Panigrahi; Avishek Kar; Sagnika Tripathy; Manoj K Mohapatra; Gunanidhi Dhangadamajhi
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

3.  TLR9 polymorphisms are associated with altered IFN-gamma levels in children with cerebral malaria.

Authors:  Nadia A Sam-Agudu; Jennifer A Greene; Robert O Opoka; James W Kazura; Michael J Boivin; Peter A Zimmerman; Melissa A Riedesel; Tracy L Bergemann; Lisa A Schimmenti; Chandy C John
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

Review 4.  Association of TLR1, TLR2, TLR4, TLR6, and TIRAP polymorphisms with disease susceptibility.

Authors:  Mamoona Noreen; Muhammad Arshad
Journal:  Immunol Res       Date:  2015-06       Impact factor: 2.829

5.  Detecting mutations in PfCRT and PfMDR1 genes among Plasmodium falciparum isolates from Saudi Arabia by pyrosequencing.

Authors:  Saad M Bin Dajem; Adel Ali H Al-Sheikh; Marie Fe Bohol; Mohammad Alhawi; Mohammed N Al-Ahdal; Ahmed Al-Qahtani
Journal:  Parasitol Res       Date:  2011-02-25       Impact factor: 2.289

6.  Toll-like receptor 9 polymorphisms influence mother-to-child transmission of human immunodeficiency virus type 1.

Authors:  Elisabetta Ricci; Sandro Malacrida; Marisa Zanchetta; Ilaria Mosconi; Marco Montagna; Carlo Giaquinto; Anita De Rossi
Journal:  J Transl Med       Date:  2010-05-25       Impact factor: 5.531

7.  Polymorphisms in the Fc gamma receptor IIIA and Toll-like receptor 9 are associated with protection against severe malarial anemia and changes in circulating gamma interferon levels.

Authors:  Elly O Munde; Winnie A Okeyo; Samwel B Anyona; Evans Raballah; Stephen Konah; Wilson Okumu; Lilian Ogonda; John Vulule; Collins Ouma
Journal:  Infect Immun       Date:  2012-10-08       Impact factor: 3.441

8.  MyD88 signaling is directly involved in the development of murine placental malaria.

Authors:  Renato Barboza; Aramys Silva Reis; Leandro Gustavo da Silva; Lutero Hasenkamp; Keitty Raquel Benevides Pereira; Niels Olsen Saraiva Câmara; Fabio Trindade Maranhão Costa; Maria Regina D'Império Lima; José Maria Alvarez; Silvia Beatriz Boscardin; Sabrina Epiphanio; Cláudio Romero Farias Marinho
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

9.  TLR9 polymorphisms in African populations: no association with severe malaria, but evidence of cis-variants acting on gene expression.

Authors:  Susana Campino; Julian Forton; Sarah Auburn; Andrew Fry; Mahamadou Diakite; Anna Richardson; Jeremy Hull; Muminatou Jallow; Fatou Sisay-Joof; Margaret Pinder; Malcolm E Molyneux; Terrie E Taylor; Kirk Rockett; Taane G Clark; Dominic P Kwiatkowski
Journal:  Malar J       Date:  2009-03-13       Impact factor: 2.979

10.  Comparative genomics of Toll-like receptor signalling in five species.

Authors:  Oliver C Jann; Annemarie King; Nestor Lopez Corrales; Susan I Anderson; Kirsty Jensen; Tahar Ait-Ali; Haizhou Tang; Chunhua Wu; Noelle E Cockett; Alan L Archibald; Elizabeth J Glass
Journal:  BMC Genomics       Date:  2009-05-11       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.